Sarah B. Noonberg Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah B. Noonberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah B. Noonberg. Sarah B. Noonberg is Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Neoleukin Therapeutics, Inc. ($AQXP) and Chief Medical Officer in Prothena Corp plc ($PRTA).
Latest Insider Trading Transactions of Sarah B. Noonberg
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NLTX, PTGX, PRTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | NLTX | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 3,700 | 25,826 | 3,600 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 4,700 | 32,806 | 7,300 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.09 | 3,700 | 92,833 | 0 | 3.7 K to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Grant | A | 6.98 | 3,700 | 25,826 | 3,700 | 0 to 3.7 K |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 26.04 | 400 | 10,416 | 0 | 400 to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.42 | 4,300 | 109,306 | 400 | 4.7 K to 400 (-91.49 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Grant | A | 6.98 | 4,700 | 32,806 | 4,700 | 0 to 4.7 K |
| May 29 2020 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 07 2020 | NLTX | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 12.84 | 25,000 | 321,000 | 25,000 | |
| Oct 15 2019 | AQXP | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 2.82 | 22,000 | 62,040 | 22,000 | |
| Oct 15 2019 | AQXP | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 2.82 | 22,000 | 62,040 | 22,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Dec 19 2017 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 17.57 | 24,000 | 421,680 | 24,000 | |
| May 18 2017 | PRTA | Prothena Corp plc | Noonberg Sarah B. | Chief Medical Offic ... | Option Exercise | A | 56.37 | 100,000 | 5,637,000 | 100,000 |
Page: 1